VMD FOI requests received between 1 July and 31 December 2016

Q: 2. Requests for Pharmacovigilance information

ATI reference number Subject ATI 408 Request for details of all adverse reactions reported following the use of an Erysipelas vaccine in sheep since Eryvac was taken off the UK market (this may have been in 2009). ATI 414 Request for the number of suspected lack of expected efficacy (SLEE) reports the VMD has received in relation to antimicrobial drugs or preparations

Q: 3. Requests for Corporate information

ATI reference number Subject ATI 409 Request for certain information about the supply of temporary agency workers ATI 417 Request for information relating to the VMD’s internal departmental plans and strategies ATI 430 Request the following most current versions of the publications if we publish them which are listed below 1. Efficiency Technical Notes Plan (ETN) 2. Contract register in open data format 3. Department Investment Strategy 4. Public Service Agreement 5. Procurement Innovation Plan 6. Estates/FM/Property Management plan 7. Asset Data

Q: 4. Requests for relating to the work of our Antimicrobial Resistance Team

ATI reference number Subject ATI 412 Request for certain information on the use of antibiotics in livestock ATI 415 Request for the number of antimicrobial drugs include antibiotics, antifungal agents and antiprotozoals prescribed in the UK, broken down: - by each drug used - by each type of animal/fish - for each year from 2010 to 2016. ATI 425 Request for “details - minutes, agendas, notes, correspondence, summaries arising etc - of the meeting held between VMD and farming industry bodies (British Poultry Council, RUMA, NFU, NPA and / or any others) on September 14th 2016 (as reported in MAVIS edition 100) to discuss GOVT AMR Review Report” ATI 426 VMD DOES NOT HOLD THIS INFORMATION Request for details of the total volume and type of antibiotics administered - broken down by antibiotic class, e.g. macrolides, tetracyclines, fluoroquinolones , others etc - to pigs entered on the “e-Med book” database set up as part of the NPA Pig Industry Antibiotic Stewardship Programme in conjunction with VMD ATI 427 Request for the minutes/notes of two meetings in 2016 at which officials from the VMD who are responsible for antibiotic-resistance policy, met with the British pork industry to specifically discuss the topic of Livestock Associated MRSA. The last meeting was on 11 October 2016

Q: 5. Requests about our information and communications technology (ICT) arrangements

ATI reference number Subject ATI 419/420/421 Request for details of: 1. expenditure on software for the years 2014/15 and 2015/16 broken down by software supplier - VMD re: ATI419 2. software contracts due to expire before 31st December 2017, broken down by supplier and date - VMD re: ATI420 3. expenditure on perpetual software licences for the years 2014/15 and 2015/16 broken down by software supplier - VMD re: ATI421 ATI 422 Request for information relating to certain contracts ATI 428 Request for the following contract information relating to the following corporate software/applications: 1. Enterprise Resource Planning Software Solutions (ERP) 2. Customer Relationship Management (CRM) Solutions 3. Human Resources (HR) and Payroll Software Solutions 4. Finance Software Solutions

Q: 6. Request for information about the Veterinary Products Committee (VPC)

ATI reference number Subject ATI 407 Request for certain information about the VPC relating to ICT expenditure ATI 410 Request for certain information about the VPC relating to temporary agency workers ATI 432 Request for certain information relating to Finance (Accounts Receivable/Payable) and IT (Information Technology)

Q: 7. Request for certain information relating to residues

ATI reference number Subject ATI 416 Request for the number of samples found to contain residue of antimicrobials EACH year from 2005 to 2016 (to date) - for each year, the range of levels of antimicrobials found in (e.g. how much the sample differed from the Maximum Residue Limit (MRL). ATI 429 Request for information on chemical residues in farmed salmon during 2014, 2015 and 2016. Listing all sampling tests and results - indicating country of origin, species of salmon, the supermarket or retail outlet, the chemical/chemicals detected, levels found, MRLs and limits of detection. And to provide specific details of all positive sampling results including laboratory reports, analyses, correspondence, letters to supermarkets and salmon farming companies and any other information pertaining to chemicals in farmed salmon since 2014

Q: 8. Request for released information

ATI reference number Subject ATI 411 Request for information relating to information the VMD released to the Hill Pony Groups following an FOI request

Question 1

1. Requests for information about certain veterinary medicinal products

Accepted Answer

ATI reference number	Subject
ATI 403	Request for information concerning Special Import Certificates for Filavac
ATI 404	Request for a copy of the actual registration documents for certain homeopathic treatments
ATI 405	Request for information on the total number of veterinary practices who have applied under the Special Import Scheme to import i) Novarvilap, or ii) Cunipravac RHD Variant between 1 January 2016 and 1 July 2016, together with the total number of vaccines requested for each product
ATI 406	Request for certain information relating to a Defra press release of 17 December 2010 titled “Alternative pet remedies: Government clampdown”. You asked for a list of all products that were targeted, all manufacturers contacted about their products, plus a list of all products a. re-branded or b. taken off sale following this action
ATI 418 VMD DOES NOT HOLD THIS INFORMATION	Request for copies of: 1. The special treatment authorisation (STA) issued by the VMD that authorised the supply of 370,000 doses of the veterinary medicinal product ‘Norvax Compact PD’ to Scottish Seafarms in 2003. and 2.The special treatment authorisation issued by the VMD that authorised the supply of 5,000 doses of the veterinary medicinal product ‘Norvax Compact PD’ to Landcatch Natural Selection in 2004-2005. 3.In the alternative, and only if the special treatment authorisations requested in points (1) and (2) cannot be located in the first instance, we request copies of any other special treatment authorisations issued by the VMD for the supply of the veterinary medicinal product ‘Norvax Compact PD’ between 1 January 2003 and 6 May 2005.
ATI 423	Request for the following information: 1. How many reports of vaccinated rabbits contracting Myxomatosis / vaccination failure for Nobivac have you received during 2016? 2. How many of these reports came from MSD direct? 3. How many of these reports came from a Vet professional? 4. How many of these reports were from a member of the public? 5. If you are able to cross check the records, how many of the reports from MSD were also reported by a Vet professional or member of the public? 6. How long , if any, is the time lag between MSD being made aware of the vaccine failure and reporting this via SARS? 7. How many reports of vaccinated rabbits contracting VHD/ vaccination failure for Nobivac have you received during 2016? 8. How many of these reports came from MSD direct? 9. How many of these reports came from a vet professional? 10. How many of these reports were from a member of the public? 11. If you are able to cross check the records, how many of the reports from MSD were also reported by a vet professional or member of the public? 12. How long , if any, is the time lag between MSD being made aware of the vaccine failure and reporting this via SARS? 13. Of the apparent instances of vaccine failure against VHD by Nobivac, how many were for RVHD strain 1 and how many were for RVHD strain 2?
ATI 424	Request for drug trial information for ivemectin and avermectin VMPs used in the environment.

Question 2

2. Requests for Pharmacovigilance information

Accepted Answer

ATI reference number	Subject
ATI 403	Request for information concerning Special Import Certificates for Filavac
ATI 404	Request for a copy of the actual registration documents for certain homeopathic treatments
ATI 405	Request for information on the total number of veterinary practices who have applied under the Special Import Scheme to import i) Novarvilap, or ii) Cunipravac RHD Variant between 1 January 2016 and 1 July 2016, together with the total number of vaccines requested for each product
ATI 406	Request for certain information relating to a Defra press release of 17 December 2010 titled “Alternative pet remedies: Government clampdown”. You asked for a list of all products that were targeted, all manufacturers contacted about their products, plus a list of all products a. re-branded or b. taken off sale following this action
ATI 418 VMD DOES NOT HOLD THIS INFORMATION	Request for copies of: 1. The special treatment authorisation (STA) issued by the VMD that authorised the supply of 370,000 doses of the veterinary medicinal product ‘Norvax Compact PD’ to Scottish Seafarms in 2003. and 2.The special treatment authorisation issued by the VMD that authorised the supply of 5,000 doses of the veterinary medicinal product ‘Norvax Compact PD’ to Landcatch Natural Selection in 2004-2005. 3.In the alternative, and only if the special treatment authorisations requested in points (1) and (2) cannot be located in the first instance, we request copies of any other special treatment authorisations issued by the VMD for the supply of the veterinary medicinal product ‘Norvax Compact PD’ between 1 January 2003 and 6 May 2005.
ATI 423	Request for the following information: 1. How many reports of vaccinated rabbits contracting Myxomatosis / vaccination failure for Nobivac have you received during 2016? 2. How many of these reports came from MSD direct? 3. How many of these reports came from a Vet professional? 4. How many of these reports were from a member of the public? 5. If you are able to cross check the records, how many of the reports from MSD were also reported by a Vet professional or member of the public? 6. How long , if any, is the time lag between MSD being made aware of the vaccine failure and reporting this via SARS? 7. How many reports of vaccinated rabbits contracting VHD/ vaccination failure for Nobivac have you received during 2016? 8. How many of these reports came from MSD direct? 9. How many of these reports came from a vet professional? 10. How many of these reports were from a member of the public? 11. If you are able to cross check the records, how many of the reports from MSD were also reported by a vet professional or member of the public? 12. How long , if any, is the time lag between MSD being made aware of the vaccine failure and reporting this via SARS? 13. Of the apparent instances of vaccine failure against VHD by Nobivac, how many were for RVHD strain 1 and how many were for RVHD strain 2?
ATI 424	Request for drug trial information for ivemectin and avermectin VMPs used in the environment.

Question 3

3. Requests for Corporate information

Accepted Answer

ATI reference number	Subject
ATI 403	Request for information concerning Special Import Certificates for Filavac
ATI 404	Request for a copy of the actual registration documents for certain homeopathic treatments
ATI 405	Request for information on the total number of veterinary practices who have applied under the Special Import Scheme to import i) Novarvilap, or ii) Cunipravac RHD Variant between 1 January 2016 and 1 July 2016, together with the total number of vaccines requested for each product
ATI 406	Request for certain information relating to a Defra press release of 17 December 2010 titled “Alternative pet remedies: Government clampdown”. You asked for a list of all products that were targeted, all manufacturers contacted about their products, plus a list of all products a. re-branded or b. taken off sale following this action
ATI 418 VMD DOES NOT HOLD THIS INFORMATION	Request for copies of: 1. The special treatment authorisation (STA) issued by the VMD that authorised the supply of 370,000 doses of the veterinary medicinal product ‘Norvax Compact PD’ to Scottish Seafarms in 2003. and 2.The special treatment authorisation issued by the VMD that authorised the supply of 5,000 doses of the veterinary medicinal product ‘Norvax Compact PD’ to Landcatch Natural Selection in 2004-2005. 3.In the alternative, and only if the special treatment authorisations requested in points (1) and (2) cannot be located in the first instance, we request copies of any other special treatment authorisations issued by the VMD for the supply of the veterinary medicinal product ‘Norvax Compact PD’ between 1 January 2003 and 6 May 2005.
ATI 423	Request for the following information: 1. How many reports of vaccinated rabbits contracting Myxomatosis / vaccination failure for Nobivac have you received during 2016? 2. How many of these reports came from MSD direct? 3. How many of these reports came from a Vet professional? 4. How many of these reports were from a member of the public? 5. If you are able to cross check the records, how many of the reports from MSD were also reported by a Vet professional or member of the public? 6. How long , if any, is the time lag between MSD being made aware of the vaccine failure and reporting this via SARS? 7. How many reports of vaccinated rabbits contracting VHD/ vaccination failure for Nobivac have you received during 2016? 8. How many of these reports came from MSD direct? 9. How many of these reports came from a vet professional? 10. How many of these reports were from a member of the public? 11. If you are able to cross check the records, how many of the reports from MSD were also reported by a vet professional or member of the public? 12. How long , if any, is the time lag between MSD being made aware of the vaccine failure and reporting this via SARS? 13. Of the apparent instances of vaccine failure against VHD by Nobivac, how many were for RVHD strain 1 and how many were for RVHD strain 2?
ATI 424	Request for drug trial information for ivemectin and avermectin VMPs used in the environment.

Question 4

4. Requests for relating to the work of our Antimicrobial Resistance Team

Accepted Answer

ATI reference number	Subject
ATI 403	Request for information concerning Special Import Certificates for Filavac
ATI 404	Request for a copy of the actual registration documents for certain homeopathic treatments
ATI 405	Request for information on the total number of veterinary practices who have applied under the Special Import Scheme to import i) Novarvilap, or ii) Cunipravac RHD Variant between 1 January 2016 and 1 July 2016, together with the total number of vaccines requested for each product
ATI 406	Request for certain information relating to a Defra press release of 17 December 2010 titled “Alternative pet remedies: Government clampdown”. You asked for a list of all products that were targeted, all manufacturers contacted about their products, plus a list of all products a. re-branded or b. taken off sale following this action
ATI 418 VMD DOES NOT HOLD THIS INFORMATION	Request for copies of: 1. The special treatment authorisation (STA) issued by the VMD that authorised the supply of 370,000 doses of the veterinary medicinal product ‘Norvax Compact PD’ to Scottish Seafarms in 2003. and 2.The special treatment authorisation issued by the VMD that authorised the supply of 5,000 doses of the veterinary medicinal product ‘Norvax Compact PD’ to Landcatch Natural Selection in 2004-2005. 3.In the alternative, and only if the special treatment authorisations requested in points (1) and (2) cannot be located in the first instance, we request copies of any other special treatment authorisations issued by the VMD for the supply of the veterinary medicinal product ‘Norvax Compact PD’ between 1 January 2003 and 6 May 2005.
ATI 423	Request for the following information: 1. How many reports of vaccinated rabbits contracting Myxomatosis / vaccination failure for Nobivac have you received during 2016? 2. How many of these reports came from MSD direct? 3. How many of these reports came from a Vet professional? 4. How many of these reports were from a member of the public? 5. If you are able to cross check the records, how many of the reports from MSD were also reported by a Vet professional or member of the public? 6. How long , if any, is the time lag between MSD being made aware of the vaccine failure and reporting this via SARS? 7. How many reports of vaccinated rabbits contracting VHD/ vaccination failure for Nobivac have you received during 2016? 8. How many of these reports came from MSD direct? 9. How many of these reports came from a vet professional? 10. How many of these reports were from a member of the public? 11. If you are able to cross check the records, how many of the reports from MSD were also reported by a vet professional or member of the public? 12. How long , if any, is the time lag between MSD being made aware of the vaccine failure and reporting this via SARS? 13. Of the apparent instances of vaccine failure against VHD by Nobivac, how many were for RVHD strain 1 and how many were for RVHD strain 2?
ATI 424	Request for drug trial information for ivemectin and avermectin VMPs used in the environment.

Question 5

5. Requests about our information and communications technology (ICT) arrangements

Accepted Answer

ATI reference number	Subject
ATI 403	Request for information concerning Special Import Certificates for Filavac
ATI 404	Request for a copy of the actual registration documents for certain homeopathic treatments
ATI 405	Request for information on the total number of veterinary practices who have applied under the Special Import Scheme to import i) Novarvilap, or ii) Cunipravac RHD Variant between 1 January 2016 and 1 July 2016, together with the total number of vaccines requested for each product
ATI 406	Request for certain information relating to a Defra press release of 17 December 2010 titled “Alternative pet remedies: Government clampdown”. You asked for a list of all products that were targeted, all manufacturers contacted about their products, plus a list of all products a. re-branded or b. taken off sale following this action
ATI 418 VMD DOES NOT HOLD THIS INFORMATION	Request for copies of: 1. The special treatment authorisation (STA) issued by the VMD that authorised the supply of 370,000 doses of the veterinary medicinal product ‘Norvax Compact PD’ to Scottish Seafarms in 2003. and 2.The special treatment authorisation issued by the VMD that authorised the supply of 5,000 doses of the veterinary medicinal product ‘Norvax Compact PD’ to Landcatch Natural Selection in 2004-2005. 3.In the alternative, and only if the special treatment authorisations requested in points (1) and (2) cannot be located in the first instance, we request copies of any other special treatment authorisations issued by the VMD for the supply of the veterinary medicinal product ‘Norvax Compact PD’ between 1 January 2003 and 6 May 2005.
ATI 423	Request for the following information: 1. How many reports of vaccinated rabbits contracting Myxomatosis / vaccination failure for Nobivac have you received during 2016? 2. How many of these reports came from MSD direct? 3. How many of these reports came from a Vet professional? 4. How many of these reports were from a member of the public? 5. If you are able to cross check the records, how many of the reports from MSD were also reported by a Vet professional or member of the public? 6. How long , if any, is the time lag between MSD being made aware of the vaccine failure and reporting this via SARS? 7. How many reports of vaccinated rabbits contracting VHD/ vaccination failure for Nobivac have you received during 2016? 8. How many of these reports came from MSD direct? 9. How many of these reports came from a vet professional? 10. How many of these reports were from a member of the public? 11. If you are able to cross check the records, how many of the reports from MSD were also reported by a vet professional or member of the public? 12. How long , if any, is the time lag between MSD being made aware of the vaccine failure and reporting this via SARS? 13. Of the apparent instances of vaccine failure against VHD by Nobivac, how many were for RVHD strain 1 and how many were for RVHD strain 2?
ATI 424	Request for drug trial information for ivemectin and avermectin VMPs used in the environment.

Question 6

6. Request for information about the Veterinary Products Committee (VPC)

Accepted Answer

ATI reference number	Subject
ATI 403	Request for information concerning Special Import Certificates for Filavac
ATI 404	Request for a copy of the actual registration documents for certain homeopathic treatments
ATI 405	Request for information on the total number of veterinary practices who have applied under the Special Import Scheme to import i) Novarvilap, or ii) Cunipravac RHD Variant between 1 January 2016 and 1 July 2016, together with the total number of vaccines requested for each product
ATI 406	Request for certain information relating to a Defra press release of 17 December 2010 titled “Alternative pet remedies: Government clampdown”. You asked for a list of all products that were targeted, all manufacturers contacted about their products, plus a list of all products a. re-branded or b. taken off sale following this action
ATI 418 VMD DOES NOT HOLD THIS INFORMATION	Request for copies of: 1. The special treatment authorisation (STA) issued by the VMD that authorised the supply of 370,000 doses of the veterinary medicinal product ‘Norvax Compact PD’ to Scottish Seafarms in 2003. and 2.The special treatment authorisation issued by the VMD that authorised the supply of 5,000 doses of the veterinary medicinal product ‘Norvax Compact PD’ to Landcatch Natural Selection in 2004-2005. 3.In the alternative, and only if the special treatment authorisations requested in points (1) and (2) cannot be located in the first instance, we request copies of any other special treatment authorisations issued by the VMD for the supply of the veterinary medicinal product ‘Norvax Compact PD’ between 1 January 2003 and 6 May 2005.
ATI 423	Request for the following information: 1. How many reports of vaccinated rabbits contracting Myxomatosis / vaccination failure for Nobivac have you received during 2016? 2. How many of these reports came from MSD direct? 3. How many of these reports came from a Vet professional? 4. How many of these reports were from a member of the public? 5. If you are able to cross check the records, how many of the reports from MSD were also reported by a Vet professional or member of the public? 6. How long , if any, is the time lag between MSD being made aware of the vaccine failure and reporting this via SARS? 7. How many reports of vaccinated rabbits contracting VHD/ vaccination failure for Nobivac have you received during 2016? 8. How many of these reports came from MSD direct? 9. How many of these reports came from a vet professional? 10. How many of these reports were from a member of the public? 11. If you are able to cross check the records, how many of the reports from MSD were also reported by a vet professional or member of the public? 12. How long , if any, is the time lag between MSD being made aware of the vaccine failure and reporting this via SARS? 13. Of the apparent instances of vaccine failure against VHD by Nobivac, how many were for RVHD strain 1 and how many were for RVHD strain 2?
ATI 424	Request for drug trial information for ivemectin and avermectin VMPs used in the environment.

Question 7

7. Request for certain information relating to residues

Accepted Answer

ATI reference number	Subject
ATI 403	Request for information concerning Special Import Certificates for Filavac
ATI 404	Request for a copy of the actual registration documents for certain homeopathic treatments
ATI 405	Request for information on the total number of veterinary practices who have applied under the Special Import Scheme to import i) Novarvilap, or ii) Cunipravac RHD Variant between 1 January 2016 and 1 July 2016, together with the total number of vaccines requested for each product
ATI 406	Request for certain information relating to a Defra press release of 17 December 2010 titled “Alternative pet remedies: Government clampdown”. You asked for a list of all products that were targeted, all manufacturers contacted about their products, plus a list of all products a. re-branded or b. taken off sale following this action
ATI 418 VMD DOES NOT HOLD THIS INFORMATION	Request for copies of: 1. The special treatment authorisation (STA) issued by the VMD that authorised the supply of 370,000 doses of the veterinary medicinal product ‘Norvax Compact PD’ to Scottish Seafarms in 2003. and 2.The special treatment authorisation issued by the VMD that authorised the supply of 5,000 doses of the veterinary medicinal product ‘Norvax Compact PD’ to Landcatch Natural Selection in 2004-2005. 3.In the alternative, and only if the special treatment authorisations requested in points (1) and (2) cannot be located in the first instance, we request copies of any other special treatment authorisations issued by the VMD for the supply of the veterinary medicinal product ‘Norvax Compact PD’ between 1 January 2003 and 6 May 2005.
ATI 423	Request for the following information: 1. How many reports of vaccinated rabbits contracting Myxomatosis / vaccination failure for Nobivac have you received during 2016? 2. How many of these reports came from MSD direct? 3. How many of these reports came from a Vet professional? 4. How many of these reports were from a member of the public? 5. If you are able to cross check the records, how many of the reports from MSD were also reported by a Vet professional or member of the public? 6. How long , if any, is the time lag between MSD being made aware of the vaccine failure and reporting this via SARS? 7. How many reports of vaccinated rabbits contracting VHD/ vaccination failure for Nobivac have you received during 2016? 8. How many of these reports came from MSD direct? 9. How many of these reports came from a vet professional? 10. How many of these reports were from a member of the public? 11. If you are able to cross check the records, how many of the reports from MSD were also reported by a vet professional or member of the public? 12. How long , if any, is the time lag between MSD being made aware of the vaccine failure and reporting this via SARS? 13. Of the apparent instances of vaccine failure against VHD by Nobivac, how many were for RVHD strain 1 and how many were for RVHD strain 2?
ATI 424	Request for drug trial information for ivemectin and avermectin VMPs used in the environment.

Question 8

8. Request for released information

Accepted Answer

ATI reference number	Subject
ATI 403	Request for information concerning Special Import Certificates for Filavac
ATI 404	Request for a copy of the actual registration documents for certain homeopathic treatments
ATI 405	Request for information on the total number of veterinary practices who have applied under the Special Import Scheme to import i) Novarvilap, or ii) Cunipravac RHD Variant between 1 January 2016 and 1 July 2016, together with the total number of vaccines requested for each product
ATI 406	Request for certain information relating to a Defra press release of 17 December 2010 titled “Alternative pet remedies: Government clampdown”. You asked for a list of all products that were targeted, all manufacturers contacted about their products, plus a list of all products a. re-branded or b. taken off sale following this action
ATI 418 VMD DOES NOT HOLD THIS INFORMATION	Request for copies of: 1. The special treatment authorisation (STA) issued by the VMD that authorised the supply of 370,000 doses of the veterinary medicinal product ‘Norvax Compact PD’ to Scottish Seafarms in 2003. and 2.The special treatment authorisation issued by the VMD that authorised the supply of 5,000 doses of the veterinary medicinal product ‘Norvax Compact PD’ to Landcatch Natural Selection in 2004-2005. 3.In the alternative, and only if the special treatment authorisations requested in points (1) and (2) cannot be located in the first instance, we request copies of any other special treatment authorisations issued by the VMD for the supply of the veterinary medicinal product ‘Norvax Compact PD’ between 1 January 2003 and 6 May 2005.
ATI 423	Request for the following information: 1. How many reports of vaccinated rabbits contracting Myxomatosis / vaccination failure for Nobivac have you received during 2016? 2. How many of these reports came from MSD direct? 3. How many of these reports came from a Vet professional? 4. How many of these reports were from a member of the public? 5. If you are able to cross check the records, how many of the reports from MSD were also reported by a Vet professional or member of the public? 6. How long , if any, is the time lag between MSD being made aware of the vaccine failure and reporting this via SARS? 7. How many reports of vaccinated rabbits contracting VHD/ vaccination failure for Nobivac have you received during 2016? 8. How many of these reports came from MSD direct? 9. How many of these reports came from a vet professional? 10. How many of these reports were from a member of the public? 11. If you are able to cross check the records, how many of the reports from MSD were also reported by a vet professional or member of the public? 12. How long , if any, is the time lag between MSD being made aware of the vaccine failure and reporting this via SARS? 13. Of the apparent instances of vaccine failure against VHD by Nobivac, how many were for RVHD strain 1 and how many were for RVHD strain 2?
ATI 424	Request for drug trial information for ivemectin and avermectin VMPs used in the environment.

VMD FOI requests received between 1 July and 31 December 2016

1. Requests for information about certain veterinary medicinal products

2. Requests for Pharmacovigilance information

3. Requests for Corporate information

4. Requests for relating to the work of our Antimicrobial Resistance Team

5. Requests about our information and communications technology (ICT) arrangements

6. Request for information about the Veterinary Products Committee (VPC)

7. Request for certain information relating to residues

8. Request for released information

Is this page useful?

Help us improve GOV.UK

Help us improve GOV.UK

ATI reference number	Subject
ATI 408	Request for details of all adverse reactions reported following the use of an Erysipelas vaccine in sheep since Eryvac was taken off the UK market (this may have been in 2009).
ATI 414	Request for the number of suspected lack of expected efficacy (SLEE) reports the VMD has received in relation to antimicrobial drugs or preparations

ATI reference number	Subject
ATI 409	Request for certain information about the supply of temporary agency workers
ATI 417	Request for information relating to the VMD’s internal departmental plans and strategies
ATI 430	Request the following most current versions of the publications if we publish them which are listed below 1. Efficiency Technical Notes Plan (ETN) 2. Contract register in open data format 3. Department Investment Strategy 4. Public Service Agreement 5. Procurement Innovation Plan 6. Estates/FM/Property Management plan 7. Asset Data

ATI reference number	Subject
ATI 412	Request for certain information on the use of antibiotics in livestock
ATI 415	Request for the number of antimicrobial drugs include antibiotics, antifungal agents and antiprotozoals prescribed in the UK, broken down: - by each drug used - by each type of animal/fish - for each year from 2010 to 2016.
ATI 425	Request for “details - minutes, agendas, notes, correspondence, summaries arising etc - of the meeting held between VMD and farming industry bodies (British Poultry Council, RUMA, NFU, NPA and / or any others) on September 14th 2016 (as reported in MAVIS edition 100) to discuss GOVT AMR Review Report”
ATI 426 VMD DOES NOT HOLD THIS INFORMATION	Request for details of the total volume and type of antibiotics administered - broken down by antibiotic class, e.g. macrolides, tetracyclines, fluoroquinolones , others etc - to pigs entered on the “e-Med book” database set up as part of the NPA Pig Industry Antibiotic Stewardship Programme in conjunction with VMD
ATI 427	Request for the minutes/notes of two meetings in 2016 at which officials from the VMD who are responsible for antibiotic-resistance policy, met with the British pork industry to specifically discuss the topic of Livestock Associated MRSA. The last meeting was on 11 October 2016

ATI reference number	Subject
ATI 419/420/421	Request for details of: 1. expenditure on software for the years 2014/15 and 2015/16 broken down by software supplier - VMD re: ATI419 2. software contracts due to expire before 31st December 2017, broken down by supplier and date - VMD re: ATI420 3. expenditure on perpetual software licences for the years 2014/15 and 2015/16 broken down by software supplier - VMD re: ATI421
ATI 422	Request for information relating to certain contracts
ATI 428	Request for the following contract information relating to the following corporate software/applications: 1. Enterprise Resource Planning Software Solutions (ERP) 2. Customer Relationship Management (CRM) Solutions 3. Human Resources (HR) and Payroll Software Solutions 4. Finance Software Solutions

ATI reference number	Subject
ATI 407	Request for certain information about the VPC relating to ICT expenditure
ATI 410	Request for certain information about the VPC relating to temporary agency workers
ATI 432	Request for certain information relating to Finance (Accounts Receivable/Payable) and IT (Information Technology)

Cookies on GOV.UK

1. Requests for information about certain veterinary medicinal products

2. Requests for Pharmacovigilance information

3. Requests for Corporate information

4. Requests for relating to the work of our Antimicrobial Resistance Team

5. Requests about our information and communications technology (ICT) arrangements

6. Request for information about the Veterinary Products Committee (VPC)

7. Request for certain information relating to residues

8. Request for released information

Is this page useful?

Help us improve GOV.UK

Help us improve GOV.UK